New evidence informs discussions on FL treatment and breast screeningDecember 20, 2019Follicular Lymphoma
Newly identified genetic changes contribute to transformation of follicular lymphomaDecember 7, 2019Follicular LymphomaB Cell Lymphoma
Rituximab maintenance has a durable benefit in follicular lymphomaNovember 19, 2019Follicular LymphomaB Cell Lymphoma
Armored CAR T cells elicit responses in NHL patientsNovember 12, 2019B Cell LymphomaDLBCLFollicular Lymphoma
Best treatment approach for early stage follicular lymphoma is unclearOctober 9, 2019Follicular LymphomaB Cell Lymphoma
ASCT may cure follicular lymphoma for some rituximab-naive patientsSeptember 24, 2019Follicular LymphomaB Cell Lymphoma
Obinutuzumab-lenalidomide combo shows promise in relapsed/refractory FLAugust 21, 2019Follicular LymphomaB Cell Lymphoma
FDA approves rituximab biosimilar for cancer, autoimmune disordersJuly 23, 2019B Cell LymphomaCLLFollicular Lymphoma
CAR T-cell therapy less effective in transformed follicular lymphomaJuly 22, 2019Follicular LymphomaB Cell LymphomaDLBCL
5F9 plus rituximab take a bite out of drug-resistant NHLJune 18, 2019B Cell LymphomaFollicular Lymphoma
Inhibitor produces high response rate in relapsed/refractory FLJune 11, 2019Follicular LymphomaB Cell Lymphoma
FDA approves lenalidomide/rituximab for previously treated FL, MZLMay 29, 2019B Cell LymphomaFollicular Lymphoma
Trial follow-up spotlights survival gains in follicular lymphomaMay 16, 2019Follicular LymphomaB Cell Lymphoma
In situ vaccination produced responses in indolent NHLApril 8, 2019B Cell LymphomaFollicular Lymphoma